Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Bionano Genomics, Inc. Director's Dealing 2018

Aug 21, 2018

35041_dirs_2018-08-21_3512c226-0bc9-4d55-9a5a-a81fce4d840b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BioNano Genomics, Inc (BNGO)
CIK: 0001411690
Period of Report: 2018-08-21

Reporting Person: TWOMEY CHRISTOPHER J (Director)